It’s Tuesday and that means we have a new podcast episode for you! Tune in to learn about standards and interoperab… https://t.co/jpWaA2FF5r
Standards and specifications to electronically share health information consistently, safely and reliably
Support for digital health implementations
Resources and enablers to accelerate clinical interoperability
What's going on in clinical interoperability and digital health
What this site is about, future plans and how to reach us
Share this page:
Welcome,
Guest
|
|
*Note: Contains "boardcode", recommend viewing on forum. Plain text email will not show corrections properly.
I have some concerns: 1. AIC: The updated description referring to foreign keys of various tables is inappropriate. The current description is better. 2. AIGc: The updated description should read: “Codes for a particular grouping of active ingredients. This is the 5 characters of the active ingredient 3. AIGn: The updated description should read: “The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). The AIGn is comprised of three portions:…” 4. NPN: The updated description refers to a DIN-HM. Are NPN and DIN-HM considered to be part of the same code system (2.16.840.1.113883.5.1107)? If yes, heading should be updated to NPN/DIN-HM (2.16.840.1.113883.5.1107). I also want to point out that several years ago (back in the SCWG days), the AIGc and AIGn were rejected as pan-Canadian standards mainly due to the fact that they are (were?) auto-generated numbers with no human review. This may have changed or may no longer be relevant, but I wanted to point it out. We want to ensure that these code systems are managed/governed as code systems should be as much as possible. Regards, Marc |
The administrator has disabled public write access.
|
|
We met with Daniel Buijs from Health Canada yesterday to review all of the Health Canada Code Systems - (CCDD, DIN, NPN, AIGn, AIGc, AIC). In the course of that conversation, we received updated information for the Code Systems - mainly updated email addresses, updated descriptions, and links for more information.
On Nov 13, we plan to update the metadata in the OID Registry for these code systems as follows: CCDD: (2.16.840.1.113883.2.20.6.1) Current: This email address is being protected from spambots. You need JavaScript enabled to view it. Updated: This email address is being protected from spambots. You need JavaScript enabled to view it. Current description: The Canadian Clinical Drug Data Set provides codes for identification and a consistent approach to naming of medications and medical devices in Canada. It has been designed and developed to reflect current clinical practice and safety advice and is freely available for use in digital health solutions and design applications. Updated description: The Canadian Clinical Drug Data Set provides codes for identification and a consistent approach to naming of medications and some medical devices in Canada. It has been designed and developed to reflect current clinical practice and safety advice and is freely available for use in digital health solutions and design applications. More information can be found here: https://infocentral.infoway-inforoute.ca/en/standards/canadian/ccdd AIC: (2.16.840.1.113883.5.1103) Current: This email address is being protected from spambots. You need JavaScript enabled to view it. Updated: This email address is being protected from spambots. You need JavaScript enabled to view it. Current description: A code assigned to any component that has medicinal properties, and supplies pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, or to affect the structure or any function of the body of man or other animals. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index_e.html Updated description: Foreign key for the Active Ingredient Table that relates active ingredients to specific products. More information can be found here: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/read-file-drug-product-database-data-extract.html AIGc (2.16.840.1.113883.5.1104) Current: This email address is being protected from spambots. You need JavaScript enabled to view it. Updated: This email address is being protected from spambots. You need JavaScript enabled to view it. Current description: Codes for particular grouping of active ingredients. This is the first 5 characters of active ingredient group number. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index_e.html Updated description: Codes for particular grouping of active ingredients. This is the 5 characters of the active ingredient code number starting at position 3 and ending at position 7. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/terminology.html AIGn: (2.16.840.1.113883.5.1106) Currrent: This email address is being protected from spambots. You need JavaScript enabled to view it. Updated: This email address is being protected from spambots. You need JavaScript enabled to view it. Current description: Codes for particular collections of active ingredients combined at specific strengths. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index_e.html Updated description: The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). The AIG is comprised of three portions: • the first portion (2 digits) identifies the number of active ingredients • the second portion(5 digits) identifies the unique groups of active ingredients(s); • the last portion (3 digits) identifies the active ingredient group strength. The strength group has a tolerance of -2% to +10%. More information can be found here: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/terminology.html DIN: (2.16.840.1.113883.5.1105) Current: This email address is being protected from spambots. You need JavaScript enabled to view it. Updated: This email address is being protected from spambots. You need JavaScript enabled to view it. Current description: A Drug Identification Number (DIN) is a number assigned by Health Canada to a drug product prior to being marketed in Canada. It consists of eight digits (numbers) generated by a computer system in the Submission and Information Policy Division. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index_e.html Updated description: A Drug Identification Number (DIN) is a computer-generated eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN uniquely identifies the following product characteristics: manufacturer; product name; active ingredient(s); strength(s) of active ingredient(s); pharmaceutical form; and route of administration. Note: The number has a leading zero More information can be found here: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-requirements-drug-identification-numbers/document.html NPN (2.16.840.1.113883.5.1107) Current: This email address is being protected from spambots. You need JavaScript enabled to view it. Updated: This email address is being protected from spambots. You need JavaScript enabled to view it. Current description: A unique identifier assigned to natural health products that have been issued a product licence by Health Canada. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/lnhpd-bdpsnh-eng.php Updated description: Natural Product Number (NPN) is an eight digit numerical code assigned to each natural health product approved to be marketed under the Natural Health Products Regulations. A Homeopathic Medicine Number (DIN-HM) is an eight digit numerical code assigned to each homeopathic medicine approved to be marketed under the Natural Health Products Regulations. More information can be found here: https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/applications-submissions/product-licensing/licensed-natural-health-products-database.html |
Last Edit: 3 months 3 weeks ago by jharper.
The administrator has disabled public write access.
|
It’s Tuesday and that means we have a new podcast episode for you! Tune in to learn about standards and interoperab… https://t.co/jpWaA2FF5r
by Infoway
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.